Depressive symptom profiles, cardio-metabolic risk and inflammation: Results from the MIDUS study.

ABSTRACT:

Background

This study aimed to (1) provide a comprehensive characterization of depressive symptoms profiles, and (2) examine the cross-sectional association between depressive symptom profiles and cardio-metabolic outcomes, including metabolic syndrome and obesity, while controlling for sociodemographic variables, health behaviors and inflammation.

Methods

Our sample was comprised of 1085 participants (55.80% female) enrolled in the MIDUS-II biomarker study. Latent profile analysis (LPA) was used to derive depressive symptom profiles using subscales of the Mood and Anxiety Symptom Questionnaire (MASQ) and the Center for Epidemiologic Studies Depression Scale (CES-D) subscales as well as Pittsburgh Sleep Quality Index (PSQI) global score. Metabolic syndrome was defined accord

SUBMITTER: Chirinos DA 

PROVIDER: S-EPMC5833295 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature